DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drugSeptember 2, 2019DiabetesCardiologyEndocrinology
Ticagrelor: Modest benefit, bigger bleed risk in diabetes plus stable CADSeptember 1, 2019DiabetesCardiologyNeurologyEndocrinology
Impact of climate change on mortality underlined by global studyAugust 21, 2019PulmonologyCardiologyInfectious Diseases
Dapagliflozin meets primary endpoint in the DAPA-HF trialAugust 21, 2019DiabetesCardiologyEndocrinology
HCV coinfection adds to cardiovascular risk in HIV-infected patientsAugust 21, 2019Preventive CareInfectious DiseasesCardiology
New biomarker model outmatches conventional risk factors for predicting mortalityAugust 20, 2019Preventive CareEndocrinologyCardiology
